IL6R and central nervous system cancer: Specifically, the covalent decoration of superparamagnetic iron oxide with interleukin-6 receptor-targeting peptide allows the particle to pass through the blood brain barrier, making it useful for the identification of low-grade glioma (Tan et al., 2019).